The Chronic Obstructive Pulmonary Disease Pipeline report embraces in-depth commercial and clinical assessment of the ...
The connected drug delivery devices market size is calculated at USD 9.18 billion in 2025 and is expected to reach around USD 61.08 billion by 2034, growing at a CAGR of 23.44%.Ottawa, Oct. 03, 2025 ...
The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.
A new international study offers hope for severely ill COVID-19 patients, showing that a widely available, low-cost drug can significantly improve survival odds. According to Professor van Haren, the ...
The acceptance comes after a study done by the American Diabetes Association in June found that inhaled insulin is safe and ...
The FDA accepted a new drug application for a single inhaler that contains beclomethasone dipropionate, formoterol fumarate ...
The FDA has accepted for review the NDA for Chiesi’s single inhaler triple therapy for the maintenance treatment of asthma in adults.
The US Food and Drug Administration is reviewing evidence about the safety and efficacy of one of the drugs used in medication abortion to investigate how it can be safely dispensed, US Health and ...
The Trump administration is touting an old generic drug as a new treatment for autism despite limited evidence, sparking unease among doctors and scientists who say the medication needs to be studied ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback